Areas of Focus
- Lipid Metabolism and Metabolic Diseases
- Phospholipid Metabolism and Tumor Microenvironment Regulation
Work Experience
- 1997/07-Present - Fudan University School of Pharmacy - Lecturer
- 1992/07-1994/08 - North China Pharmaceutical Group Antibiotics Research Institute - Assistant Engineer
Academic Background & Achievements
- 2003/09-2008/03 PhD in Biochemistry and Molecular Biology: Fudan University
- 1994/09-1997/07 Master's in Biochemical Pharmacy: China Pharmaceutical University
- 1988/09-1992/07 Bachelor's in Biopharmaceuticals: China Pharmaceutical University
Publications
- Synthesis and Antitumor Evaluation of Novel Hybrids of Phenylsulfonylfuroxan and Estradiol Derivatives, Wan, Q., Deng, Y., Huang, Y., Yu, Z., Wang, C., Wang, K., Dong, J., Chen, Y., 2019
- Evacetrapib reduces preβ-1 HDL in patients with atherosclerotic cardiovascular disease or diabetes, Chen Y, Dong J, Zhang X, Chen X, Wang L, Chen H, Ge J, Jiang XC, 2019
- Discovery of N-hydroxy-3-alkoxybenzamides as direct acid sphingomyelinase inhibitors using a ligand-based pharmacophore model, Yang K, Nong K, Gu Q, Dong J, Wang J, 2018
- Synthesis and evaluation of xanthone derivatives as acid sphingomyelinase inhibitors: potential treatment for UV-induced skin damage, Yang K, Gao B, Ming X, Huang Z, Wang M, Dong J, Wang J, 2017
- Human serum preβ1-high density lipoprotein levels are independently and negatively associated with coronary artery diseases, Chen Y, Dong J, Chen X, Jiang H, Bakillah A, Zhang X, Li Z, Yin J, Liang D, Zou Y, Hussain M, Cuchel M, Rader D, Chen H, Ge J, Jiang XC, 2016
- Chinese hamster ovary-sphingomyelin synthase2 biospecific extraction and liquid chromatography with tandem mass spectrometry analysis for the prediction of bioactive components of Rhizoma Polygoni Cuspidati, Xue Y, Dong J, Liang J, 2016